Proxy Voting Records Glossary
    
Fidelity Advisor Biotechnology Fund
For the 12 month period: Jul 1, 2007 and Jun 30, 2008
AMYLIN PHARMACEUTICALS, INC.
Meeting Type: Annual Ticker: AMLNSecurity ID: 032346108
Meeting Date: May 30, 2008
Proposed by: Management Back to Meetings
# ProposalManagement
Recommendation		 Vote
1.1 ELECT ADRIAN ADAMS AS A DIRECTOR For For
1.2 ELECT STEVEN R. ALTMAN AS A DIRECTOR For For
1.3 ELECT TERESA BECK AS A DIRECTOR For For
1.4 ELECT DANIEL M. BRADBURY AS A DIRECTOR For For
1.5 ELECT JOSEPH C. COOK, JR. AS A DIRECTOR For For
1.6 ELECT KARIN EASTHAM AS A DIRECTOR For For
1.7 ELECT JAMES R. GAVIN III AS A DIRECTOR For For
1.8 ELECT GINGER L. GRAHAM AS A DIRECTOR For For
1.9 ELECT HOWARD E. GREENE, JR. AS A DIRECTOR For For
1.10 ELECT JAY S. SKYLER AS A DIRECTOR For For
1.11 ELECT JOSEPH P. SULLIVAN AS A DIRECTOR For For
1.12 ELECT JAMES N. WILSON AS A DIRECTOR For For
2 TO APPROVE AN INCREASE OF 3,500,000 SHARES IN THE AGGREGATE NUMBER OF SHARES OF THE COMPANY S COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE COMPANY S 2001 EQUITY INCENTIVE PLAN. For Against
3 TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY OR ITS FISCAL YEAR ENDING DECEMBER 31, 2008. For For
 
 Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions.
 
 
© Copyright 1998-2009 FMR LLC.
All rights reserved.
Terms of Use  Privacy  Security  Site Map